// Company Overview //
| Stock Name | 药明合联 |
|---|---|
| Stock Code | 02268 |
| Company Full Name | 药明合联 |
| Industry | 醫療保健 |
| Principal Activities | 公司是專注于全球ADC及更廣泛生物偶聯藥物市場的領先CRDMO，亦是一家致力于提供全面綜合服務的公司。 |
| Listing Date | 2023-11-17 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省無錫市新吳區新輝環路11號 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | https://wuxixdc.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Offering Mechanism | 未知 |
|---|---|
| Clawback Tiers | No data |
| Prospectus Date | 2023-11-07 |
| Offer Price | HK$ 20.60 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 10,300 |
| Par Value | No data |
| Global Offering Shares | — |
| HK Public Offering Shares | — (0%) |
| International Placing Shares | — (0%) |
| Offer Ratio | No data |
| Total Shares Post-IPO | No data |
| Total Global Offering Size | HK$ — |
| Public Offering Size | HK$ — (0%) |
| Oversubscription Multiple | —x |
| Valid Applications | 30,727 |
| Accepted Applications | — |
| Reallocation | No |
| Total Funds Raised | HK$ 1,102,800,400 |
| Greenshoe (Over-allotment Option) | No data |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
|---|---|
| Pre-IPO Valuation (Last Round) | No data |
| P/E Ratio | 139.76 |
| Profit/Loss Status | No data |
| Period-End Cash Balance | No data |
| Listing Expenses | ~HK$ 192,690,000 |
| Listing Expenses / Funds Raised | No data |
| Total Pre-IPO Investment | No data |
// First Day Performance
| First Day Close | Loading... |
|---|---|
| First Day Open | HK$ 2.3 |
| First Day Change | -2.30% |
| First Day Volume | 66988000.0 |
| First Day Turnover | 159746000.0 |
// Price Chart //
Loading...
// Use of Proceeds
| Use of Proceeds | 1、約67%或2,333.8百萬港元將用于(i)在新加坡興建我們的設施及(ii)擴大我們在中國的服務實力及能力，以進一步擴大服務實力及能力； 2、約23%或801.2百萬港元將用于有選擇地尋求戰略聯盟、投資及收購機會，主要旨在擴大技術平臺及服務類型和能力； 3、約10%或348.3百萬港元用作營運資金及其他一般公司用途。 |
|---|
// Underwriting Syndicate //
联席保荐人 (3)
摩根士丹利亚洲有限公司
高盛（亚洲）有限责任公司
摩根大通证券(远东)有限公司
整体协调人 (6)
摩根士丹利亚洲有限公司
高盛（亚洲）有限责任公司
J.P. Morgan Securities (Asia Pacific) Limited
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
华泰金融控股（香港）有限公司
联席账簿管理人 (6)
摩根士丹利亚洲有限公司
高盛（亚洲）有限责任公司
J.P. Morgan Securities (Asia Pacific) Limited
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
华泰金融控股（香港）有限公司
联席牵头经办人 (6)
摩根士丹利亚洲有限公司
高盛（亚洲）有限责任公司
J.P. Morgan Securities (Asia Pacific) Limited
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
华泰金融控股（香港）有限公司
// Cornerstone Investors //
Allotment Results Announcement
| # | Investor Name | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|
| 1 | HongShan Funds 234.7港元 | 11,391,000 | 6.38% | 5.76% | — | — |
| 2 | Lake Bleu Funds 78.2港元 | 3,797,000 | 2.13% | 1.92% | — | — |
// Directors & Management //
| Chairman | 陳智勝 |
|---|---|
| Company Secretary | 席曉捷 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 藥明生物技術有限公司(50.91%);合全藥業香港投資有限公司(33.94%) |
|---|
// Allotment Benchmarks //
Pool A (Small Subscriptions)
| Shares Applied | Applicants | Allottees | Expected Lots |
|---|---|---|---|
| 500 | 12,488 | 1,623 | 0.13 |
| 1,000 | 1,887 | 490 | 0.26 |
| 1,500 | 896 | 349 | 0.39 |
| 2,000 | 5,476 | 2,843 | 0.52 |
| 2,500 | 996 | 646 | 0.65 |
| 3,000 | 357 | 277 | 0.78 |
| 3,500 | 226 | 204 | 0.90 |
| 4,000 | 514 | 16 | 1.03 |
| 4,500 | 436 | 69 | 1.16 |
| 5,000 | 1,277 | 366 | 1.29 |
| 6,000 | 259 | 141 | 1.54 |
| 7,000 | 180 | 144 | 1.80 |
| 8,000 | 178 | 10 | 2.06 |
| 9,000 | 1,181 | 370 | 2.31 |
| 10,000 | 805 | 459 | 2.57 |
| 15,000 | 417 | 357 | 3.85 |
| 20,000 | 339 | 47 | 5.14 |
| 25,000 | 235 | 100 | 6.42 |
| 30,000 | 183 | 130 | 7.71 |
| 35,000 | 116 | 115 | 8.99 |
| 40,000 | 113 | 31 | 10.27 |
| 45,000 | 102 | 57 | 11.56 |
| 50,000 | 285 | 237 | 12.83 |
| 60,000 | 107 | 27 | 15.25 |
| 70,000 | 73 | 55 | 17.75 |
| 80,000 | 75 | 22 | 20.29 |
| 90,000 | 37 | 30 | 22.81 |
| 100,000 | 188 | 64 | 25.34 |
| 125,000 | 83 | 56 | 31.68 |
| 150,000 | 77 | 1 | 38.01 |
| 175,000 | 34 | 12 | 44.34 |
| 200,000 | 46 | 31 | 50.68 |
| 225,000 | 105 | 99 | 54.95 |
Pool B (Large Subscriptions)
| Shares Applied | Applicants | Allottees | Expected Lots |
|---|---|---|---|
| 250,000 | 669 | 138 | 55.20 |
| 500,000 | 104 | 104 | 56.00 |
| 750,000 | 48 | 48 | 57.00 |
| 1,000,000 | 61 | 61 | 58.00 |
| 2,000,000 | 28 | 28 | 59.20 |
| 3,000,000 | 8 | 8 | 60.00 |
| 4,000,000 | 3 | 3 | 60.80 |
| 5,000,000 | 5 | 5 | 62.00 |
| 6,000,000 | 3 | 3 | 63.60 |
| 7,000,000 | 1 | 1 | 64.40 |
| 8,922,500 | 25 | 25 | 64.24 |
| 93,839,657 | 1 | 1 | 14244.86 |
Allotment Benchmarks
